A research group is investigating the association between a newly approved anti-obesity medication and the incidence of acute cholecystitis. In an initial prospective observational cohort study, the crude relative risk of acute cholecystitis in patients taking the new medication compared to those on standard lifestyle interventions is 2.2 (95% CI: 1.6-2.9).
During data review, the investigators observe that the new medication was disproportionately prescribed to patients with a baseline body mass index (BMI) > 40 kg/m². They subsequently stratify the data by baseline BMI. In the stratum of patients with a BMI > 40 kg/m², the relative risk is 1.1 (95% CI: 0.8-1.5). In the stratum of patients with a BMI ≤ 40 kg/m², the relative risk is also 1.1 (95% CI: 0.9-1.4).
The research group is now planning a subsequent observational cohort study to further investigate this relationship. They want to ensure that baseline BMI does not distort the association, and they specifically wish to address this issue during the design phase of the new study.
Which of the following methods is most appropriate to achieve this goal?
- Matching exposed and unexposed subjects by baseline body mass indexAnswer
- BAdjusting for body mass index using multivariable logistic regression
- CPerforming a stratified analysis by body mass index categories
- DSelecting study participants randomly from a national health registry
- EIncreasing the overall study sample size to enhance statistical power